John R. Pawloski, M.D., Ph.D., Chief of Hematology at the John B. Amos Cancer Center, has been named a Distinguished Cancer Scholar by the Georgia Cancer Coalition. The honor comes with a $500,000 grant over five years to support clinical research efforts at the John B. Amos Cancer Center.
“Clearly, Dr. Pawloski is an accomplished hematological oncologist, with a strong record of funding and publications,” said Bill Todd, former president and Chief Executive Officer of the Georgia Cancer Coalition, which recently merged with the Georgia Research Alliance. The alliance is a nonprofit corporation that is a public/private partnership of the state’s universities, leading corporations and state government.
“In recent years, the Coalition placed a more strategic emphasis on embedding scholars within local communities to help build bridges between our state’s academic medical centers and community cancer centers, where 85 percent of care is delivered,” Todd continued. “I am confident that Dr. Pawloski will make valuable contributions in this regard.”
“We are very proud of Dr. Pawloski and this very deserved recognition,” said Kevin Sass, CEO of Doctors Hospital and senior administrator of the John B. Amos Cancer Center. “The Distinguished Cancer Scholar program will enable us to continue our mission to ensure our community has access to the most advanced and comprehensive care close to home.”
Dr. Pawloski will use this award to develop a Center for Integrative HematoOncology to probe the heretofore neglected interface between human hematologic systems and the efficacy of cancer therapeutics. For example, his studies will address associations between anemia (low hemoglobin), iron metabolism, and hemostasis/thrombosis, and the outcomes of therapies for various solid tumor cancers (e.g. breast, lung, colon, etc.). His long-term goals are to develop an autologous transplant program, with the possible expansion into regenerative medicine therapies as this technology advances.
“I am quite honored to receive this award. It is a fitting tribute to the emerging regional reputation of the John B. Amos Cancer Center, its physicians and staff,” said Dr. Pawloski. “The Cancer Center is committed to building a clinical research program at the community level as we advance the search for novel therapies for cancer and hematological disorders. The greater Columbus community has a strong tradition of giving, even when times are tough, and we view this award as one way to give something back to the people of Columbus.”
The John B. Amos Cancer Center participated in more than 50 clinical trials last year in areas including breast, colon, lung, prostate and hematologic cancers.
Dr. Pawloski received his undergraduate degree from the University of Michigan–Flint. He earned his M.D. and Ph.D. from the Physician-Scientist program at the St. Louis University School of Medicine. He then completed post-graduate training as an intern, resident and clinical-investigator fellow in internal medicine, followed by a fellowship in hematology, at Duke University Medical Center. Dr. Pawloski subsequently served for six years as an Assistant Professor of Medicine in the Division of Hematology at Duke University Medical Center, where he was the principle investigator on multiple research grants totaling over $1 million.
Prior to joining the John B. Amos Cancer Center, he served for three years as Chief of Hematology at Allegheny General Hospital in Pittsburgh, Penn., where he was promoted to Associate Professor of Medicine at the Drexel University College of Medicine.
He is a member of the American Society of Hematology and the American Society of Clinical Oncology.